Alan B. Sandler, Chief Development Officer at Revolution Medicines, sold RVMD on Sep 16, 2026
Data as of Oct 16
▼ SELL$67K336 shares at $199.30Alan B. Sandler Chief Development OfficerRVMD Revolution Medicines, Inc.
- Traded
- Sep 16, 2026
- Disclosed
- Sep 18, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RVMD since disclosure
−6.8%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Sep 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLAlan B. Sandler Chief Development OfficerRVMD Revolution Medicines, Inc.$975disclosed Sep 18 · filed 2 days after the trade